Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep 10;322(10):977-979.
doi: 10.1001/jama.2019.10508.

Prevalence of Oral HPV Infection in Unvaccinated Men and Women in the United States, 2009-2016

Affiliations

Prevalence of Oral HPV Infection in Unvaccinated Men and Women in the United States, 2009-2016

Anil K Chaturvedi et al. JAMA. .

Erratum in

Abstract

To estimate changes in oral human papillomavirus (HPV) prevalence attributable to vaccination vs herd immunity, this national survey study uses National Health and Nutrition Examination Survey data to compare oral HPV prevalence for 4 types targeted by HPV vaccine and 33 nonvaccine types in unvaccinated US adults aged 18 to 59 years from 2009 to 2016.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Gillison reported consulting for Amgen, Aspyrian, AstraZeneca, Bayer, Bristol-Myers Squibb, Celgene, EMD Serono, Genocea, GlaxoSmithKline, Lilly, NewLink, Merck, Roche, and TRN Oncology; receiving grants from the National Institute of Dental and Craniofacial Research (NIDCR); and receiving personal fees from Roche Diagnostics. No other disclosures were reported.

Figures

Figure.
Figure.. Prevalence Estimates and Ratios for Vaccine-Type and Nonvaccine-Type Oral HPV Infections Among Unvaccinated Men and Women Aged 18-59 Years, NHANES, 2009-2016
Human papillomavirus (HPV) prevalence data shown across 4 National Health and Nutrition Examination Survey (NHANES) cycles (2009-2010, 2011-2012, 2013-2014, and 2015-2016). HPV-16/-18/-6/-11 were considered vaccine types. Prevalence ratios were adjusted for age, race/ethnicity, education-level, marital status, smoking, and lifetime number of same- and opposite-sex oral sex partners. Prevalence trends across cycles were assessed using integer scores and quantified through odds ratios and 95% confidence intervals (CIs). Individuals with missing covariate values for education (n = 8), marital status (n = 5), or smoking (n = 895) were imputed the modal value. Individuals with missing lifetime (n = 1606) number of oral sex partners were imputed the sex-specific mean. All analyses accounted for the complex sample design, including the use of sample weights adjusted for unit nonresponse and the combination of 4 cycles. Weights were further poststratified to the age × sex × race distribution of the cycle-specific US population to account for nonparticipation in the sexual behavioral questionnaire or oral HPV components. Error bars indicate 95% CIs.

Comment in

Similar articles

Cited by

References

    1. Petrosky E, Bocchini JA Jr, Hariri S, et al. ; Centers for Disease Control and Prevention . Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2015;64(11):300-304. - PMC - PubMed
    1. Chaturvedi AK, Graubard BI, Broutian T, et al. . Effect of prophylactic human papillomavirus (HPV) vaccination on oral HPV infections among young adults in the United States. J Clin Oncol. 2017;36(3):262-267. doi:10.1200/JCO.2017.75.0141 - DOI - PMC - PubMed
    1. Malagón T, Laurie C, Franco EL. Human papillomavirus vaccination and the role of herd effects in future cancer control planning: a review. Expert Rev Vaccines. 2018;17(5):395-409. doi:10.1080/14760584.2018.1471986 - DOI - PubMed
    1. Gillison ML, Broutian T, Pickard RK, et al. . Prevalence of oral HPV infection in the United States, 2009-2010. JAMA. 2012;307(7):693-703. doi:10.1001/jama.2012.101 - DOI - PMC - PubMed
    1. Drolet M, Bénard É, Boily MC, et al. . Population-level impact and herd effects following human papillomavirus vaccination programmes. Lancet Infect Dis. 2015;15(5):565-580. doi:10.1016/S1473-3099(14)71073-4 - DOI - PMC - PubMed

Substances